|
CCDC66 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.75270000002392E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.58399999997216E-06 |
| Normal-vs-Stage2 |
2.072100E-02 |
| Normal-vs-Stage3 |
1.87329999956631E-07 |
| Normal-vs-Stage4 |
1.043060E-03 |
| Stage1-vs-Stage2 |
3.041000E-01 |
| Stage1-vs-Stage3 |
2.198800E-01 |
| Stage1-vs-Stage4 |
5.666600E-01 |
| Stage2-vs-Stage3 |
8.851700E-02 |
| Stage2-vs-Stage4 |
6.752200E-01 |
| Stage3-vs-Stage4 |
1.574820E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.05269999997704E-07 |
| Normal-vs-AfricanAmerican |
9.098400E-02 |
| Normal-vs-Asian |
4.388000E-01 |
| Caucasian-vs-AfricanAmerican |
1.411710E-02 |
| Caucasian-vs-Asian |
1.265560E-02 |
| AfricanAmerican-vs-Asian |
1.823790E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.66420000002887E-07 |
| Normal-vs-Female |
1.100510E-03 |
| Male-vs-Female |
1.007710E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.763600E-04 |
| Normal-vs-Age(41-60Yrs) |
1.7380099999964E-05 |
| Normal-vs-Age(61-80Yrs) |
3.17829999996189E-06 |
| Normal-vs-Age(81-100Yrs) |
1.096550E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.560800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.072800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.604400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.250200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.016000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.738000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.124400E-01 |
| Normal-vs-Grade 2 |
5.68719999999301E-05 |
| Normal-vs-Grade 3 |
7.35219995995351E-09 |
| Normal-vs-Grade 4 |
4.552600E-04 |
| Grade 1-vs-Grade 2 |
1.296560E-01 |
| Grade 1-vs-Grade 3 |
1.100100E-02 |
| Grade 1-vs-Grade 4 |
1.122190E-01 |
| Grade 2-vs-Grade 3 |
3.937600E-02 |
| Grade 2-vs-Grade 4 |
6.553000E-01 |
| Grade 3-vs-Grade 4 |
3.498000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.71485000000082E-05 |
| Normal-vs-ccB subtype |
1.67600000000601E-06 |
| ccA subtype-vs-ccB subtype |
4.767800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.24239999999654E-05 |
| Normal-vs-N1 |
1.658810E-03 |
| N0-vs-N1 |
3.687200E-01 |
|
|
